Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
2021 · Vaccine · 115 citations
https://doi.org/10.1016/j.vaccine.2021.01.055
A
Arnaud M. Didierlaurent
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
129
Papers
8.8K
Citations
43
h-index
72
i10-index
Arnaud M. Didierlaurent is an academic researcher from University of Geneva. The author has contributed to research in topics: Immunotherapy and Immune Responses & Immune Response and Inflammation & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 43, co-authored 110 publications.
ORCID: 0000-0002-4736-9003Papers by this author
worksCentral Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
2016 · Scientific Reports · 112 citations
https://doi.org/10.1038/srep39475
Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial
2016 · Clinical Immunology · 110 citations
https://doi.org/10.1016/j.clim.2016.05.007
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity
2021 · Cell Reports · 91 citations
https://doi.org/10.1016/j.celrep.2021.109773
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
2021 · npj Vaccines · 58 citations
https://doi.org/10.1038/s41541-021-00337-0
Non‐clinical safety and biodistribution of AS03‐adjuvanted inactivated pandemic influenza vaccines
2015 · Journal of Applied Toxicology · 33 citations
https://doi.org/10.1002/jat.3130
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat